Strata Oncology Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
82
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$6.15M
- Investors
-
14
Strata Oncology General Information
Description
Operator of an oncology company intended to accelerate the impact of precision medicine for patients with cancer. The company partners with major healthcare systems across the country, which systematically send their cancer patients' biopsies to high-throughput CLIA labs for genomic sequencing, with results provided to the oncologist within days, indicating the tumor profile, and matching appropriate therapies and drug trials, enabling healthcare providers to provide actionable insight to the lives of cancer patients.
Contact Information
Website
www.strataoncology.comCorporate Office
- 8192 Jackson Road
- Suite A
- Ann Arbor, MI 48103
- United States
Corporate Office
- 8192 Jackson Road
- Suite A
- Ann Arbor, MI 48103
- United States
Strata Oncology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 22-Nov-2024 | $6.15M | Completed | Generating Revenue | ||
| 3. Later Stage VC (Series C) | 28-Jul-2021 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 23-May-2018 | $26M | $38M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 02-Jun-2016 | $12M | $12M | Completed | Startup |
Strata Oncology Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series C-1 | ||||||||
| Series B | 2,625,918 | $0.000010 | 8% | $9.9 | $9.9 | 1x | $9.9 | 22.34% |
| Series A | 3,054,529 | $0.000010 | 8% | $4.04 | $4.04 | 1x | $4.04 | 25.99% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Strata Oncology Comparisons
Industry
Financing
Details
Strata Oncology Competitors (23)
One of Strata Oncology’s 23 competitors is Advanced Cell Diagnostics, a Formerly VC-backed company based in Minneapolis, MN.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Advanced Cell Diagnostics | Formerly VC-backed | Minneapolis, MN | ||||
| Foundation Medicine | Formerly VC-backed | Boston, MA | ||||
| GeneCast Biotechnology | Private Equity-Backed | Wuxi, China | ||||
| Empire Genomics | Formerly PE-Backed | Depew, NY | ||||
| Cardiff Oncology | Formerly Angel backed | San Diego, CA |
Strata Oncology Patents
Strata Oncology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023383478-A1 | Methods of determining cancer therapy effectiveness | Pending | 17-Nov-2022 | ||
| EP-4619754-A2 | Methods of determining cancer therapy effectiveness | Pending | 17-Nov-2022 | ||
| US-20260193716-A1 | Methods of determining cancer therapy effectiveness | Pending | 17-Nov-2022 | ||
| WO-2024108174-A2 | Methods of determining cancer therapy effectiveness | Inactive | 17-Nov-2022 | ||
| WO-2024108174-A3 | Methods of determining cancer therapy effectiveness | Inactive | 17-Nov-2022 | G16H20/10 |
Strata Oncology Signals
Strata Oncology Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cormorant Asset Management | PE/Buyout | Minority | ||
| Highside Capital Management | Hedge Fund | Minority | ||
| Angel (individual) | Minority | |||
| Monashee Investment Management | Hedge Fund | Minority | ||
| Revelation Partners | Venture Capital | Minority |
Strata Oncology FAQs
-
When was Strata Oncology founded?
Strata Oncology was founded in 2015.
-
Where is Strata Oncology headquartered?
Strata Oncology is headquartered in Ann Arbor, MI.
-
What is the size of Strata Oncology?
Strata Oncology has 82 total employees.
-
What industry is Strata Oncology in?
Strata Oncology’s primary industry is Decision/Risk Analysis.
-
Is Strata Oncology a private or public company?
Strata Oncology is a Private company.
-
What is Strata Oncology’s current revenue?
The current revenue for Strata Oncology is .
-
How much funding has Strata Oncology raised over time?
Strata Oncology has raised $134M.
-
Who are Strata Oncology’s investors?
Cormorant Asset Management, Highside Capital Management, , Monashee Investment Management, and Revelation Partners are 5 of 14 investors who have invested in Strata Oncology.
-
Who are Strata Oncology’s competitors?
Advanced Cell Diagnostics, Foundation Medicine, GeneCast Biotechnology, Empire Genomics, and Cardiff Oncology are some of the 23 competitors of Strata Oncology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process